S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
Log in

OTCMKTS:ARZTY - ARYZTA AG/ADR Stock Price, Forecast & News

$0.42
-0.08 (-15.82 %)
(As of 02/25/2020 04:00 PM ET)
Today's Range
$0.42
Now: $0.42
$0.42
50-Day Range
$0.47
MA: $0.52
$0.57
52-Week Range
$0.27
Now: $0.42
$0.73
Volume11,524 shs
Average Volume5,005 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ARYZTA AG provides frozen B2B baking solutions in Europe, North America, and internationally. It offers bread rolls and artisan loaves, sweet baked goods and morning goods, and savoury and other products. The company also provides asset management services; and distributes food products. It serves large retail, convenience, and independent retailers, as well as quick service restaurants and other foodservice customers. The company has 56 bakeries in 29 countries. ARYZTA AG was founded in 1897 and is based in Zurich, Switzerland.

Industry, Sector and Symbol

Industry Food: Specialty/Candy
Sub-IndustryN/A
SectorConsumer Non-Durables
Current SymbolOTCMKTS:ARZTY
CUSIPN/A
CIKN/A
Phone(144) 583-4200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees18,895
Next Earnings DateN/A
OptionableNot Optionable

Receive ARZTY News and Ratings via Email

Sign-up to receive the latest news and ratings for ARZTY and its competitors with MarketBeat's FREE daily newsletter.


ARYZTA AG/ADR (OTCMKTS:ARZTY) Frequently Asked Questions

What is ARYZTA AG/ADR's stock symbol?

ARYZTA AG/ADR trades on the OTCMKTS under the ticker symbol "ARZTY."

Has ARYZTA AG/ADR been receiving favorable news coverage?

News articles about ARZTY stock have been trending very negative on Tuesday, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. ARYZTA AG/ADR earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for ARYZTA AG/ADR.

Who are some of ARYZTA AG/ADR's key competitors?

What other stocks do shareholders of ARYZTA AG/ADR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARYZTA AG/ADR investors own include First Solar (FSLR), Eyepoint Pharmaceuticals (EYPT), Euronet Worldwide (EEFT), Sorrento Therapeutics (SRNE), CVS Health (CVS), Cisco Systems (CSCO), Vodafone Group (VOD), Reckitt Benckiser Group (RB), Greencore Group (GNC) and CRH (CRH).

Who are ARYZTA AG/ADR's key executives?

ARYZTA AG/ADR's management team includes the folowing people:
  • Mr. Kevin E. Toland F.C.M.A., FCMA, CEO & Exec. Director (Age 54)
  • Mr. Anthony Murphy, Chief People Officer (Age 56)
  • Mr. Robert O'Boyle, Chief Operating Officer of APMEA (Age 44)
  • Mr. Frédéric Pflanz, Chief Financial Officer (Age 51)
  • Mr. Paul Meade, Head of Investor Relations

How do I buy shares of ARYZTA AG/ADR?

Shares of ARZTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ARYZTA AG/ADR's stock price today?

One share of ARZTY stock can currently be purchased for approximately $0.42.

What is ARYZTA AG/ADR's official website?

The official website for ARYZTA AG/ADR is http://www.aryzta.com/.

How can I contact ARYZTA AG/ADR?

The company can be reached via phone at (144) 583-4200.


MarketBeat Community Rating for ARYZTA AG/ADR (OTCMKTS ARZTY)

Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about ARYZTA AG/ADR and other stocks. Vote "Outperform" if you believe ARZTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARZTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel